接口协调工程乳化剂通过HIF1信号通路调节牙周炎治疗中的骨免疫微环境,诱导代谢重编程
Hui Zhang1,2,3, Xiao Huang1, Rui Chen1,4
1College of Medicine, Southwest Jiaotong University, Chengdu, Sichuan, 610031, P. R. China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|September 29, 2025
概括
一种新型的注射乳膜,HIPPE-QU,重编程巨细胞代谢,以对抗牙周炎引起的免疫失调,并促进组织修复. 这种方法为精确的牙周免疫微环境调节提供了一个有希望的策略.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 牙周病学 牙周病学
背景情况:
- 牙周炎涉及免疫失调和受损的组织再生.
- 巨细胞代谢重编程是治疗干预的关键目标.
- 开发可注射,多功能生物材料对于牙周治疗至关重要.
研究的目的:
- 开发一种用于治疗牙周炎的多功能高内部相皮克林乳液 (HIPPE-QU).
- 研究HIPPE-QU重新编程巨细胞代谢并促进牙周组织再生的能力.
- 评估HIPPE-QU. 的协同抗菌和免疫调节作用.
主要方法:
- 一步同质化制造HIPPE-QU,由凝纳米粒子和HA-Cu共同稳定.
- 素 (QU) 的封装用于持续的,对pH反应的释放.
- 实验室内对巨细胞代谢 (糖解,ATP,HIF-1信号传递,ROS) 和极化进行的研究.
- 在体内评估炎症,BMSC骨质生成能力和牙周组织再生.
主要成果:
- HIPPE-QU,一种可注射乳膜,证明了持续的和响应pH的QU释放.
- HIPPE-QU调节了巨细胞代谢,抑制了ROS,并促进了M1-M2两极分化.
- 在体内研究显示,炎症减少,恢复BMSC骨质生成能力,增强牙周再生.
结论:
- HIPPE-QU 作为一种针对牙周炎的创新性免疫重编程平台.
- 该研究强调了空间组织的药物负载对协同效应的潜力.
- 这种方法为精确调制牙周免疫微环境提供了转化潜力.
相关概念视频
Inflammatory Response
16.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.0K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K


